OTKA-115723
A lipid homeosztázis metabolikus, hormonális és genetikai tényezői nagy kardiovaszkuláris kockázatú betegekben
start date: 2015-11-01
end date: 2019-10-31
Publication list
2022
Nádró, B.,
Lőrincz, H.,
Juhász, L.,
Szentpéteri, A.,
Sztanek, F.,
Varga, É.,
Páll, D.,
Paragh, G.,
Harangi, M.:
Determination of Serum Progranulin in Patients with Untreated Familial Hypercholesterolemia.
Biomedicines. 10 (4), 1-15, 2022.
Journal metrics:
Q2 Biochemistry, Genetics and Molecular Biology (miscellaneous)
Q1 Medicine (miscellaneous)
2021
Nádró, B.,
Lőrincz, H.,
Molnár, Á.,
Szentpéteri, A.,
Zöld, E.,
Seres, I.,
Páll, D.,
Paragh, G.,
Kempler, P.,
Harangi, M.,
Sztanek, F.:
Effects of alpha-lipoic acid treatment on serum progranulin levels and inflammatory markers in diabetic neuropathy.
J. Int. Med. Res. 49 (5), 1-13, 2021.
Journal metrics:
Q3 Biochemistry
Q3 Biochemistry (medical)
Q4 Cell Biology
Q3 Medicine (miscellaneous)
2020
Sztanek, F.,
Lőrincz, H.,
Molnár, Á.,
Szentpéteri, A.,
Zöld, E.,
Seres, I.,
Páll, D.,
Harangi, M.,
Kempler, P.,
Paragh, G.:
Effect of alpha-lipoic acid treatment on plasma asymmetric dimethylarginine, a biomarker of endothelial dysfunction in diabetic neuropathy.
Arch. Med. Sci. 2020 1-9, 2020.
Journal metrics:
Q1 Medicine (miscellaneous)
2018
Varga, V.,
Lőrincz, H.,
Szentpéteri, A.,
Juhász, L.,
Seres, I.,
Paragh, G.,
Balla, J.,
Paragh, G.,
Harangi, M.:
Changes in serum afamin and vitamin E levels after selective LDL apheresis.
J. Clin. Apheresis. 33 (5), 569-575, 2018.
Journal metrics:
Q2 Hematology
Q1 Medicine (miscellaneous)
Somodi, S.,
Seres, I.,
Lőrincz, H.,
Harangi, M.,
Fülöp, P.,
Paragh, G.:
Plasminogen activator inhibitor-1 level correlates with lipoprotein subfractions in obese non-diabetic subjects.
Int. J. Endocrinol. 2018 1-9, 2018.
Journal metrics:
Q2 Endocrine and Autonomic Systems
Q2 Endocrinology
Q2 Endocrinology, Diabetes and Metabolism
2017
Harangi, M.,
Szentpéteri, A.,
Nádró, B.,
Lőrincz, H.,
Seres, I.,
Páll, D.,
Paragh, G.:
HDL subfraction distribution and HDL function in untreated dyslipidemic patients.
VP. 1 166-173, 2017.
updated: 2024-11-10, 02:24
